Event
Animal Health, Nutrition & Technology Innovation – Shaping the Future of Animal Health
Monday, March 2, 2026 - Tuesday, March 3, 2026
Event Details
DateMonday, March 2, 2026 - Tuesday, March 3, 2026
Convene Sancroft, St. Paul's, London, UK
Click here for more information.
Panel: Investor Briefing Part 1: State of the Industry – Factors fuelling growth and deal flow | Monday, March 2, 2026
10:15 a.m. – 11:15 a.m. GMT
Industry partners most heavily involved in transactions across the ecosystem will share a data driven view of the market and discuss activity over the last 5 years and what we can expect in the next 5. Sidley partner Robert Darwin will moderate this panel.
Panel: Commercialisation Journeys – Charting Global Pathways in Regulation and Policy | Tuesday, March 3, 2026
12:10 p.m. – 12:40 p.m. GMT
Bringing innovation to market means navigating complex and often fragmented regulatory pathways. This panel explores the regulatory hurdles that shape timelines, costs, and strategic choices, highlighting the global differences that influence market access. Panelists will also consider whether greater harmonisation across regions is possible, or even desirable, and what that could mean for innovators. Sidley partner Chris Boyle will moderate this panel.
10:15 a.m. – 11:15 a.m. GMT
Industry partners most heavily involved in transactions across the ecosystem will share a data driven view of the market and discuss activity over the last 5 years and what we can expect in the next 5. Sidley partner Robert Darwin will moderate this panel.
Panel: Commercialisation Journeys – Charting Global Pathways in Regulation and Policy | Tuesday, March 3, 2026
12:10 p.m. – 12:40 p.m. GMT
Bringing innovation to market means navigating complex and often fragmented regulatory pathways. This panel explores the regulatory hurdles that shape timelines, costs, and strategic choices, highlighting the global differences that influence market access. Panelists will also consider whether greater harmonisation across regions is possible, or even desirable, and what that could mean for innovators. Sidley partner Chris Boyle will moderate this panel.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025U.S. FDA's Adoption of ICH E6(R3) Good Clinical Practice: Key Takeaways for Sponsors and InvestigatorsDecember 4, 2025Sidley Represents PayRange in Its Acquisition of KioSoftDecember 1, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory